OmniAb (OABI) Enterprise Value (2021 - 2026)
OmniAb's (OABI) quarterly Enterprise Value came in at -$49.1 million in Q1 2026, down 12.56% year-on-year from -$56.1 million in Q1 2025, and down 1.01% on a QoQ basis from -$48.6 million in Q4 2025.
OmniAb (OABI) Enterprise Value (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Enterprise Value data on file, last reported at -$49.1 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 12.56% year-over-year to -$49.1 million in Q1 2026; TTM through Mar 2026 was -$49.1 million, a 12.56% decrease from a year earlier, with the FY2025 full-year figure at -$48.6 million, up 18.26% from the prior year.
- Enterprise Value for Q1 2026 stood at -$49.1 million, down from -$48.6 million in the prior quarter.
- Over the last five years, Enterprise Value for OABI reached as high as -$19847.0 in Q3 2022 and fell as low as -$113.6 million in Q1 2023.
- Historically, Enterprise Value has averaged -$57.5 million across 5 years, with a median of -$59.4 million in 2024.
- Across the five-year window, Enterprise Value soared 94.52% in 2022 and sank 486764.51% in 2023, its largest moves.
- Year by year, Enterprise Value stood at -$88.3 million in 2022, then advanced by 1.45% to -$87.0 million in 2023, then jumped by 31.67% to -$59.4 million in 2024, then gained by 18.26% to -$48.6 million in 2025, then declined by 1.01% to -$49.1 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$49.1 million in Q1 2026, -$48.6 million in Q4 2025, and -$59.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | -49.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.07 Mn |
| Dec 31, 2025 | -48.58 Mn |
| Sep 30, 2025 | -59.50 Mn |
| Jun 30, 2025 | -41.62 Mn |
| Mar 31, 2025 | -43.60 Mn |
| Dec 31, 2024 | -59.43 Mn |
| Sep 30, 2024 | -59.38 Mn |
| Jun 30, 2024 | -57.23 Mn |
| Mar 31, 2024 | -69.01 Mn |
| Dec 31, 2023 | -86.98 Mn |
| Sep 30, 2023 | -96.63 Mn |
| Jun 30, 2023 | -103.15 Mn |
| Mar 31, 2023 | -113.61 Mn |
| Dec 31, 2022 | -88.27 Mn |
| Sep 30, 2022 | -19,847.00 |
| Jun 30, 2022 | -159,194.00 |
| Mar 31, 2022 | -434,629.00 |
| Sep 30, 2021 | -362,203.00 |
| Jun 30, 2021 | -36,145.00 |